FEEDBACK
PLEASE WAIT ...
CLOSE
CLOSE

Country

Industries

  • Medicine ‎1
    • Tissue Engineering ‎1

Contact Info

Location

Nanoxis AB

  • 1Product
  • 1Types
  • 1Industry

About Company

Nanoxis is a biotechnology company with extensive knowledge and experience in membrane protein research. Based on our unique LPI™ technology we offer products and services to membrane protein researchers worldwide. Roughly 70% percent of all major drugs sold today target membrane proteins linked to diseases such as diabetes, hypertension, asthma, cancer, obesity, schizophrenia, Parkinson�s, depression and epilepsy. For two thirds of all anticipated new

Nanoxis is a biotechnology company with extensive knowledge and experience in membrane protein research. Based on our unique LPI™ technology we offer products and services to membrane protein researchers worldwide. Roughly 70% percent of all major drugs sold today target membrane proteins linked to diseases such as diabetes, hypertension, asthma, cancer, obesity, schizophrenia, Parkinson�s, depression and epilepsy. For two thirds of all anticipated new drugs it has been predicted that they will need to act on membrane proteins.

Products

LPI FlowCell

MEDICINE - TISSUE ENGINEERING   |  PROTEIN MEMBRANE IMMOBILIZER

LPI FlowCell

Application :

Ligand binding studies,Biomarker,Epitope identification,Profiling,Quantification

Analytical Reports